265
		Pathologic assessment of response to neoadjuvant chemotherapy in ovarian cancer: correlation with survival
	
					
	
	Pathologic assessment of response to neoadjuvant chemotherapy in ovarian cancer: correlation with survival
	Saturday, March 28, 2015: 9:55 AM
	Salon C-D (Hilton Chicago)
	
	
	
		
	
		
	
		
			
			 